US stocks traded lower this morning with the Dow Jones falling more than 100 points on Tuesday.
After Tuesday’s market open, the Dow fell 0.31% to 33,524.12, while the NASDAQ fell 0.11% to 11,352.46. The S&P 500 was also down 0.30% to 4,007.66.
Leading and lagging sectors
- Consumer discretionary stocks gained 0.2% on Tuesday. Meanwhile top winner in the sector included Bed Bath & Beyond Inc. BBBYby 16% and Bassett Furniture Industries, Incorporated BSETincreased by 5%.
- In Tuesday trading, materials shares fell 1%.
top heading
Verizon Communications Inc vz reported better than expected fourth quarter sales results.
Verizon reported revenue growth of 3.5% year over year to $35.3 billion in the fourth quarter of FY22, beating the consensus of $35.1 billion. Adjusted EPS of $1.19 was in line with consensus.
Verizon said it expects adjusted earnings per share to be in the range of $4.55 to $4.85, below the consensus of $4.99.
Stock trading UP
- Baudax Bio, Inc. BXRX Shares rose 83% to $5.76 after the company announced the results of its first interim analysis in a Phase II study of BX1000 for neuromuscular blockade in patients undergoing elective surgery.
- shares of Grom Social Enterprises, Inc. GROM got a boost and shot up 31% to $2.90.
- Compass Therapeutics, Inc. CMPX Shares were also higher, gaining 18% to $4.49. Compass Therapeutics recently announced that its combination therapy demonstrated an overall response rate of approximately 38% in previously treated patients with bile duct cancer.
Stocks are trading down
- Satixfy Communications Ltd. SATX Shares fell 41% to $4.2485. SatixFy recently appointed Ido Gur as its new Chief Executive Officer.
- shares of Altamira Therapeutics Ltd. CYTO fell 30% to $3.4905 after the company provided an update on its clinical trials of Bentrio. The COVAMID study did not meet the primary efficacy endpoint.
- Cassava Sciences,…
[ad_2]
Source story
